Aging
Navigate
Back to articleFigure 4(5 of 13)
100%
Figure 4
Figure 4.BrdU-treatment of MRC-5 cells effectively inhibits DNA-synthesis and induces Beta-Galactosidase. Two-day treatment with BrdU significantly reduced DNA synthesis in MRC-5 fibroblasts by ~70%, as measured with the Muse cell cycle kit. MRC-5 cells after 8 days of BrdU treatment were positively stained for Beta-Galactosidase. n=3; * p < 0.05.
Figure 4 — Azithromycin and Roxithromycin define a new family of “senolytic” drugs that target senescent human fibroblasts | Aging